EUVIMEDEUVIMED entdecken
Crossref

Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice

Jiawei Zhang, Haoliang Shi, Xuan Qin, Pengcheng Wang, Yufan Ling iD, Xiangbowen Jin, Mingyue Cui, Bin Song, Houyu Wang iD, Yao He iD

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.5c05187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Jiawei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials & Collaborative Innovation Center of Suzhou Nano Science and Technology (NANO-CIC), Soochow University,…. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Cyclobutanes, Heterocyclic Compounds, Photosensitizing Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Afterglow occurring after light excitation ceases offers a safer light source to the laser-activated verteporfin therapy approved by the FDA for choroidal neovascularization (CNV). However, conventional afterglow molecules, especially adamantane-dioxetanes with high steric hindrance, exhibit limited chemiexcitation, restricting electron transfer and diminishing therapeutic effects. Here, we constructed ultrabright afterglow nanosystems by integrating low-hindrance cyclobutane moieties into the dioxetane framework. Among these cyclobutane substituents, the benzyl oxocyclobutane-dioxetane is the brightest afterglow molecule due to its lowest hindrance, showing 35.7 times faster relative chemiexcitation rate and 59 times higher afterglow intensity than adamantane-dioxetane, alongside a three-order-of-magnitude increase in total afterglow emission. Consequently, at the equivalent concentration, the benzyl oxocyclobutane-dioxetane-based nanosystem produces nearly five times more singlet oxygen than free verteporfin. In a CNV mouse model, cyclic treatment with our nanosystem reduced lesion areas by 64.9%, outperforming the 39.3% reduction achieved by free verteporfin counterpart. By eliminating the need for laser activation, this strategy minimizes ocular damage, providing a safe and effective treatment for CNV and other retinal disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal NeovascularizationCyclobutanesHeterocyclic CompoundsPhotosensitizing AgentsAnimalsMicePhotochemotherapy

Substanzen

CyclobutanesHeterocyclic CompoundsPhotosensitizing Agents

Autor:innen und Institutionen

  • Institute of Functional Nano & Soft Materials & Collaborative Innovation Center of Suzhou Nano Science and Technology (NANO-CIC), Soochow University, Suzhou 215123, China.
  • State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, P. R. China.
  • Macao Translational Medicine Center, Macau University of Science and Technology, Taipa, Macau 999078, SAR, China.
  • Macao Institute of Materials Science and Engineering, Macau University of Science and Technology, Taipa, Macau 999078, SAR, China.

ORCID-Profile: Yufan Ling, Houyu Wang, Yao He

Förderung

  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Suzhou Applied Basic Research Science and Technology Innovation Program

Zitieren

APA

Zhang, J., Shi, H., Qin, X., Wang, P., Ling, Y., Jin, X., Cui, M., Song, B., Wang, H., & He, Y. (2025). Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c05187

Vancouver

Zhang J, Shi H, Qin X, Wang P, Ling Y, Jin X, et al. Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c05187

BibTeX
@article{Zhang2025,
  author = {Zhang, Jiawei and Shi, Haoliang and Qin, Xuan and Wang, Pengcheng and Ling, Yufan and Jin, Xiangbowen and Cui, Mingyue and Song, Bin and Wang, Houyu and He, Yao},
  title = {Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.5c05187}
}
Kostenlos starten →